In ovarian cancer, METTL3 activity has been reported to accelerate cell proliferation and migration by regulating transcription of AXL receptor tyrosine kinase (AXL, referring to the Greek term “anexelekto”, which means uncontrolled) [13, 14]. Here, AXL is linked to ovarian carcinoma.